News

Opinion
Zacks Investment Research on MSN12hOpinion
Bull of the Day: Hims & Hers Health (HIMS)
Hims & Hers Health (HIMS) is quickly becoming one of the most compelling stories in the market as an emerging powerhouse in the direct-to-consumer healthcare space. The stock has posted outsized gains ...
Allied health workers are essential to providing quality healthcare in rural areas where medical professionals are often scarce. These regions face unique challenges, such as limited access to care, ...
The medication finasteride has become popular among young men. But for those struggling to conceive, it could be the reason.
The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.
Hims & Hers will begin offering generic semaglutide drugs in Canada next year after Novo Nordisk lost its exclusive patent ...
Real-time decision support demands an IT network that can handle the volume and velocity of clinical data, while maintaining ...
Rush University System for Health is building out its suite of digital health offerings with a new direct-to-consumer ...
GoodRx Holdings, Inc. (NASDAQ:GDRX) is one of the 13 Best Healthcare Stocks to Buy Under $10. On June 13, Leerink Partners ...
With the upgraded telehealth and digital care platform, Rush University's health system says it aims to bring more patients ...
A new Ohio law championed by the Cleveland APL will expand access to veterinary care by allowing veterinarians to establish ...
Sen. John Hickenlooper (D-CO) joined pro-abortion activists and abortion providers for a panel discussion on his proposed ...
Discover the dramatic rise in US abortions through Telehealth, fueled by proactive states and evolving regulations.